SARS-CoV2 billion-compound docking

被引:0
|
作者
David M. Rogers
Rupesh Agarwal
Josh V. Vermaas
Micholas Dean Smith
Rajitha T. Rajeshwar
Connor Cooper
Ada Sedova
Swen Boehm
Matthew Baker
Jens Glaser
Jeremy C. Smith
机构
[1] Oak Ridge National Laboratory,Computing and Computational Sciences Directorate
[2] Oak Ridge National Laboratory,UT/ORNL Center for Molecular Biophysics
[3] The University of Tennessee,Department of Biochemistry and Cellular and Molecular Biology
[4] Knoxville,MSU
[5] Michigan State University,DOE Plant Research Laboratory
[6] Oak Ridge National Laboratory,Biological Sciences Division
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
This dataset contains ligand conformations and docking scores for 1.4 billion molecules docked against 6 structural targets from SARS-CoV2, representing 5 unique proteins: MPro, NSP15, PLPro, RDRP, and the Spike protein. Docking was carried out using the AutoDock-GPU platform on the Summit supercomputer and Google Cloud. The docking procedure employed the Solis Wets search method to generate 20 independent ligand binding poses per compound. Each compound geometry was scored using the AutoDock free energy estimate, and rescored using RFScore v3 and DUD-E machine-learned rescoring models. Input protein structures are included, suitable for use by AutoDock-GPU and other docking programs. As the result of an exceptionally large docking campaign, this dataset represents a valuable resource for discovering trends across small molecule and protein binding sites, training AI models, and comparing to inhibitor compounds targeting SARS-CoV-2. The work also gives an example of how to organize and process data from ultra-large docking screens.
引用
收藏
相关论文
共 50 条
  • [31] Developing lectins as inhibitors of SARS-CoV2
    Guseman, Alex J.
    Murphy, Linda
    Nambulli, Sham
    Bhinderwhala, Fatema
    Duprex, Paul
    Gronenborn, Angela M.
    BIOPHYSICAL JOURNAL, 2022, 121 (03) : 332A - 332A
  • [32] A Citywide Approach to SARS-CoV2 Testing
    Broach, John P.
    Lowell, Monica
    Brown, Olga
    Martin, Clayton
    Muller, Michelle
    Shirshac, Jeanne
    Perrone, Domenica
    Smith, Will
    Castiel, Matilde
    Kobayashi, Kimiyoshi J.
    Lapriore, Cheryl M.
    Dickson, Eric W.
    Babu, Kavita M.
    FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [33] Sensitivity and specificity of two WHO approved SARS-CoV2 antigen assays in detecting patients with SARS-CoV2 infection
    Jeewandara, Chandima
    Guruge, Dinuka
    Pushpakumara, Pradeep Darshana
    Madhusanka, Deshan
    Jayadas, Tibutius Thanesh
    Chaturanga, Indika Prasad
    Aberathna, Inoka Sepali
    Danasekara, Saubhagya
    Pathmanathan, Thilagaraj
    Jayathilaka, Deshni
    Somathilaka, Gayasha
    Kuruppu, Heshan
    Gomes, Laksiri
    Gunasekara, Vitjith
    Wijayamuni, Ruwan
    Ogg, Graham S.
    Malavige, Gathsaurie Neelika
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [34] Surviving the Rookie Virus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): The Immunopathology of a SARS-CoV2 Infection
    Tsai, Sheng Feng
    Lu, Kang-Yun
    Chuang, Hong-Meng
    Liu, Ching-Ann
    CELL TRANSPLANTATION, 2021, 30
  • [35] Sensitivity and specificity of two WHO approved SARS-CoV2 antigen assays in detecting patients with SARS-CoV2 infection
    Chandima Jeewandara
    Dinuka Guruge
    Pradeep Darshana Pushpakumara
    Deshan Madhusanka
    Tibutius Thanesh Jayadas
    Indika Prasad Chaturanga
    Inoka Sepali Aberathna
    Saubhagya Danasekara
    Thilagaraj Pathmanathan
    Deshni Jayathilaka
    Gayasha Somathilaka
    Heshan Kuruppu
    Laksiri Gomes
    Vitjith Gunasekara
    Ruwan Wijayamuni
    Graham S. Ogg
    Gathsaurie Neelika Malavige
    BMC Infectious Diseases, 22
  • [36] Identification of potential natural inhibitors of SARS-CoV2 main protease by molecular docking and simulation studies
    Gupta, Sanjay
    Singh, Atul Kumar
    Kushwaha, Prem Prakash
    Prajapati, Kumari Sunita
    Shuaib, Mohd
    Senapati, Sabyasachi
    Kumar, Shashank
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (12): : 4334 - 4345
  • [37] Impact of low molecular weight heparin (LMWH) on SARS-CoV2 Infection: HEPARIN SARS-CoV2 clinical trial.
    Otero Candelera, Remedios
    Gonzalez-Vergara, Demetrio
    Caparros, Isabel
    Garcia-Ortega, Alberto
    Rodriguez-Matute, Consolacion
    Moises, Jorge
    Marin-Barrera, Lucia
    Rodriguez-Martorell, Javier
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [38] Advances in the computational analysis of SARS-COV2 genome
    J. A. Tenreiro Machado
    J. M. Rocha-Neves
    Filipe Azevedo
    J. P. Andrade
    Nonlinear Dynamics, 2021, 106 : 1525 - 1555
  • [39] The SARS-CoV2 pandemic and routine immunisation Comment
    Kang, Gagandeep
    LANCET GLOBAL HEALTH, 2022, 10 (02): : E155 - E156
  • [40] The impact of inhaled corticosteroid on SARS-CoV2 infection
    Lai, Chih-Cheng
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (07): : 2939 - 2940